BFS
NNNN

Bare Financial Services’s Anbio Biotechnology NNNN Stock Holding History

Bare Financial Services’s Portfolio NNNN Stock Details NNNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$385 Buy
+15
New +$391 ﹤0.01% 1672

Other funds holding NNNN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $3.28B AUM 23.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Bare Financial Services's NNNN Position: Q1 2026 in Review

Bare Financial Services opened a new position in Anbio Biotechnology (NNNN) in Q1 2026: 15 shares worth $385. The stake represents ﹤0.01% of the portfolio and ranks #1672 among its holdings.

8 funds tracked by Wall St. Rank hold NNNN as of Q1 2026.

  • Bare Financial Services held 15 shares of Anbio Biotechnology worth $385 as of Q1 2026.
  • Anbio Biotechnology was a new Bare Financial Services position in Q1 2026.
  • Anbio Biotechnology made up ﹤0.01% of Bare Financial Services's portfolio in Q1 2026, its #1672 holding.
  • 8 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.